Frequency Therapeutics, Inc. Rings the Closing Bell in Celebration of its IPO

ABOUT THIS EVENT

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases by activating progenitor cells within the body, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, David Lucchino, Co-Founder, President & Chief Executive Officer, rang the Closing Bell.